{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:42:59Z","timestamp":1787002979604,"version":"build-2736575974"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52285-7","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T09:03:44Z","timestamp":1727427824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Proteogenomic characterization of skull-base chordoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Qilin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1086-8896","authenticated-orcid":false,"given":"Yunzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-0268","authenticated-orcid":false,"given":"Zhaoyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruofan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1683-4280","authenticated-orcid":false,"given":"Jinwen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1094-4019","authenticated-orcid":false,"given":"Fuchu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8673-3464","authenticated-orcid":false,"given":"Chen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"52285_CR1","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/S1470-2045(11)70337-0","volume":"13","author":"BP Walcott","year":"2012","unstructured":"Walcott, B. P. et al. Chordoma: current concepts, management, and future directions. Lancet Oncol. 13, e69\u2013e76 (2012).","journal-title":"Lancet Oncol."},{"key":"52285_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3171\/jns.2001.95.2.0175","volume":"95","author":"HA Crockard","year":"2001","unstructured":"Crockard, H. A. et al. A multidisciplinary team approach to skull base chordomas. J. Neurosurg. 95, 175\u2013183 (2001).","journal-title":"J. Neurosurg."},{"key":"52285_CR3","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.3390\/curroncol29040191","volume":"29","author":"RGC Santegoeds","year":"2022","unstructured":"Santegoeds, R. G. C. et al. Ectopic recurrence of skull base chordoma after proton therapy. Curr. Oncol. 29, 2364\u20132375 (2022).","journal-title":"Curr. Oncol."},{"key":"52285_CR4","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1016\/S1470-2045(14)71190-8","volume":"16","author":"S Stacchiotti","year":"2015","unstructured":"Stacchiotti, S. & Sommer, J. Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol. 16, e71\u2013e83 (2015).","journal-title":"Lancet Oncol."},{"key":"52285_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09633-9","volume":"10","author":"S Groschel","year":"2019","unstructured":"Groschel, S. et al. Defective homologous recombination DNA repair as therapeutic target in advanced chordoma. Nat. Commun. 10, 1635 (2019).","journal-title":"Nat. Commun."},{"key":"52285_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00701-021-04768-5","volume":"163","author":"J Cahill","year":"2021","unstructured":"Cahill, J. et al. Gamma knife stereotactic radiosurgery for the treatment of chordomas and chondrosarcomas. Acta Neurochir. (Wien) 163, 1003\u20131011 (2021).","journal-title":"Acta Neurochir. (Wien)"},{"key":"52285_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01026-0","volume":"8","author":"PS Tarpey","year":"2017","unstructured":"Tarpey, P. S. et al. The driver landscape of sporadic chordoma. Nat. Commun. 8, 890 (2017).","journal-title":"Nat. Commun."},{"key":"52285_CR8","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/ng.454","volume":"41","author":"XR Yang","year":"2009","unstructured":"Yang, X. R. et al. T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat. Genet. 41, 1176\u20131178 (2009).","journal-title":"Nat. Genet."},{"key":"52285_CR9","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41586-022-04789-9","volume":"606","author":"RM Drews","year":"2022","unstructured":"Drews, R. M. et al. A pan-cancer compendium of chromosomal instability. Nature 606, 976\u2013983 (2022).","journal-title":"Nature"},{"key":"52285_CR10","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41586-022-04738-6","volume":"606","author":"CD Steele","year":"2022","unstructured":"Steele, C. D. et al. Signatures of copy number alterations in human cancer. Nature 606, 984\u2013991 (2022).","journal-title":"Nature"},{"key":"52285_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s43657-023-00103-3","volume":"3","author":"T Song","year":"2023","unstructured":"Song, T. et al. Integrative identification by Hi-C revealed distinct advanced structural variations in lung adenocarcinoma tissue. Phenomics 3, 390\u2013407 (2023).","journal-title":"Phenomics"},{"key":"52285_CR12","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41571-021-00518-9","volume":"18","author":"M Ott","year":"2021","unstructured":"Ott, M., Prins, R. M. & Heimberger, A. B. The immune landscape of common CNS malignancies: implications for immunotherapy. Nat. Rev. Clin. Oncol. 18, 729\u2013744 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"52285_CR13","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10143-021-01576-4","volume":"45","author":"JW Bai","year":"2022","unstructured":"Bai, J. W. et al. Mid-term follow-up surgical results in 284 cases of clival chordomas: the risk factors for outcome and tumor recurrence. Neurosurg. Rev. 45, 1451\u20131462 (2022).","journal-title":"Neurosurg. Rev."},{"key":"52285_CR14","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.wneu.2018.02.127","volume":"115","author":"O Sanusi","year":"2018","unstructured":"Sanusi, O., Arnaout, O., Rahme, R. J., Horbinski, C. & Chandler, J. P. Surgical resection and adjuvant radiation therapy in the treatment of skull base chordomas. World Neurosurg. 115, e13\u2013e21 (2018).","journal-title":"World Neurosurg."},{"key":"52285_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3340\/jkns.2021.0240","volume":"65","author":"B Wang","year":"2022","unstructured":"Wang, B., Tian, F. & Tong, X. Clinical grading system, surgical outcomes and prognostic analysis of cranial base chordomas. J. Korean Neurosurg. Soc. 65, 469\u2013478 (2022).","journal-title":"J. Korean Neurosurg. Soc."},{"key":"52285_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21026-5","volume":"12","author":"J Bai","year":"2021","unstructured":"Bai, J. et al. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival. Nat. Commun. 12, 757 (2021).","journal-title":"Nat. Commun."},{"key":"52285_CR17","doi-asserted-by":"publisher","first-page":"e18846","DOI":"10.1371\/journal.pone.0018846","volume":"6","author":"LP Le","year":"2011","unstructured":"Le, L. P. et al. Recurrent chromosomal copy number alterations in sporadic chordomas. PLoS ONE 6, e18846 (2011).","journal-title":"PLoS ONE"},{"key":"52285_CR18","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1593\/neo.12526","volume":"14","author":"RJ Diaz","year":"2012","unstructured":"Diaz, R. J. et al. High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis. Neoplasia 14, 788\u2013U141 (2012).","journal-title":"Neoplasia"},{"key":"52285_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/gcc.1184","volume":"32","author":"S Scheil","year":"2001","unstructured":"Scheil, S. et al. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line. U CHI. Gene Chromosome Canc. 32, 203\u2013211 (2001).","journal-title":"U CHI. Gene Chromosome Canc."},{"key":"52285_CR20","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.devcel.2021.07.009","volume":"56","author":"DA Lukow","year":"2021","unstructured":"Lukow, D. A. et al. Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies. Dev. Cell 56, 2427\u20132439 e2424 (2021).","journal-title":"Dev. Cell"},{"key":"52285_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jhep.2018.02.029","volume":"69","author":"LQ Dong","year":"2018","unstructured":"Dong, L. Q. et al. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma. J. Hepatol. 69, 89\u201398 (2018).","journal-title":"J. Hepatol."},{"key":"52285_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cancers11020226","volume":"11","author":"CC Lepage","year":"2019","unstructured":"Lepage, C. C., Morden, C. R., Palmer, M. C. L., Nachtigal, M. W. & McManus, K. J. Detecting chromosome instability in cancer: approaches to resolve cell-to-cell heterogeneity. Cancers (Basel) 11, 226 (2019).","journal-title":"Cancers (Basel)"},{"key":"52285_CR23","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1016\/j.cell.2022.06.007","volume":"185","author":"J Biermann","year":"2022","unstructured":"Biermann, J. et al. Dissecting the treatment-naive ecosystem of human melanoma brain metastasis. Cell 185, 2591\u20132608.e30 (2022).","journal-title":"Cell"},{"key":"52285_CR24","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/s41588-023-01419-6","volume":"55","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. A complete telomere-to-telomere assembly of the maize genome. Nat. Genet. 55, 1221\u20131231 (2023).","journal-title":"Nat. Genet."},{"key":"52285_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41592-022-01512-4","volume":"19","author":"YF Mao","year":"2022","unstructured":"Mao, Y. F. & Zhang, G. J. A complete, telomere-to-telomere human genome sequence presents new opportunities for evolutionary genomics. Nat. Methods 19, 635\u2013638 (2022).","journal-title":"Nat. Methods"},{"key":"52285_CR26","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.3390\/cancers15235690","volume":"15","author":"GL Tang","year":"2023","unstructured":"Tang, G. L. et al. Cytogenetic profile in monoclonal gammopathy of undetermined significance, smoldering and symptomatic multiple myeloma: a study of 1087 patients with highly purified plasma cells. Cancers 15, 5690 (2023).","journal-title":"Cancers"},{"key":"52285_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1215\/S1152851703000231","volume":"6","author":"DJ Brat","year":"2004","unstructured":"Brat, D. J. et al. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from radiation therapy oncology group trials. Neuro Oncol. 6, 96\u2013103 (2004).","journal-title":"Neuro Oncol."},{"key":"52285_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00008390-200506000-00003","volume":"15","author":"L Casorzo","year":"2005","unstructured":"Casorzo, L. et al. Fluorescence hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis. Melanoma Res. 15, 155\u2013160 (2005).","journal-title":"Melanoma Res."},{"key":"52285_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10048-009-0217-x","volume":"11","author":"AL Vital","year":"2010","unstructured":"Vital, A. L. et al. Intratumoral patterns of clonal evolution in gliomas. Neurogenetics 11, 227\u2013239 (2010).","journal-title":"Neurogenetics"},{"key":"52285_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ceb.2021.01.004","volume":"70","author":"K Krupina","year":"2021","unstructured":"Krupina, K., Goginashvili, A. & Cleveland, D. W. Causes and consequences of micronuclei. Curr. Opin. Cell Biol. 70, 91\u201399 (2021).","journal-title":"Curr. Opin. Cell Biol."},{"key":"52285_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41556-017-0011-1","volume":"20","author":"YW Chan","year":"2018","unstructured":"Chan, Y. W., Fugger, K. & West, S. C. Unresolved recombination intermediates lead to ultra-fine anaphase bridges, chromosome breaks and aberrations. Nat. Cell Biol. 20, 92\u2013103 (2018).","journal-title":"Nat. Cell Biol."},{"key":"52285_CR32","doi-asserted-by":"publisher","first-page":"7870","DOI":"10.1038\/s41598-018-26168-z","volume":"8","author":"M Chmielewska","year":"2018","unstructured":"Chmielewska, M. et al. The programmed DNA elimination and formation of micronuclei in germ line cells of the natural hybridogenetic water frog. Sci. Rep. Uk 8, 7870 (2018).","journal-title":"Sci. Rep. Uk"},{"key":"52285_CR33","doi-asserted-by":"publisher","first-page":"e0214159","DOI":"10.1371\/journal.pone.0214159","volume":"14","author":"M Ranieri","year":"2019","unstructured":"Ranieri, M. et al. Green olive leaf extract (OLE) provides cytoprotection in renal cells exposed to low doses of cadmium. PLoS ONE 14, e0214159 (2019).","journal-title":"PLoS ONE"},{"key":"52285_CR34","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1200\/JCO.2016.69.4406","volume":"35","author":"MJ Ellis","year":"2017","unstructured":"Ellis, M. J. et al. Ki67 proliferation index as a tool for chemotherapy decisions during and after neoadjuvant aromatase inhibitor treatment of breast cancer: results from the American college of surgeons oncology group Z1031 trial (Alliance). J. Clin. Oncol. 35, 1061\u20131069 (2017).","journal-title":"J. Clin. Oncol."},{"key":"52285_CR35","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1091\/mbc.02-02-0030","volume":"13","author":"ML Whitfield","year":"2002","unstructured":"Whitfield, M. L. et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 13, 1977\u20132000 (2002).","journal-title":"Mol. Biol. Cell"},{"key":"52285_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrc1802","volume":"6","author":"ML Whitfield","year":"2006","unstructured":"Whitfield, M. L., George, L. K., Grant, G. D. & Perou, C. M. Common markers of proliferation. Nat. Rev. Cancer 6, 99\u2013106 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"52285_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-018-0567-9","volume":"10","author":"JZ Yuan","year":"2018","unstructured":"Yuan, J. Z. et al. Single-cell transcriptome analysis of lineage diversity in high-grade glioma. Genome Med. 10, 57 (2018).","journal-title":"Genome Med."},{"key":"52285_CR38","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/j.cell.2020.10.044","volume":"183","author":"F Petralia","year":"2020","unstructured":"Petralia, F. et al. Integrated proteogenomic characterization across major histological types of pediatric brain cancer. Cell 183, 1962\u20131985.e31 (2020).","journal-title":"Cell"},{"key":"52285_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/neuonc\/noab207","volume":"24","author":"D Wang","year":"2022","unstructured":"Wang, D. et al. A novel PLK1 inhibitor onvansertib effectively sensitizes MYC-driven medulloblastoma to radiotherapy. Neuro Oncol. 24, 414\u2013426 (2022).","journal-title":"Neuro Oncol."},{"key":"52285_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41576-019-0171-x","volume":"21","author":"U Ben-David","year":"2020","unstructured":"Ben-David, U. & Amon, A. Context is everything: aneuploidy in cancer. Nat. Rev. Genetics 21, 44\u201362 (2020).","journal-title":"Nat. Rev. Genetics"},{"key":"52285_CR41","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ng1861","volume":"38","author":"SL Carter","year":"2006","unstructured":"Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genetics 38, 1043\u20131048 (2006).","journal-title":"Nat. Genetics"},{"key":"52285_CR42","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.cell.2013.10.011","volume":"155","author":"T Davoli","year":"2013","unstructured":"Davoli, T. et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155, 948\u2013962 (2013).","journal-title":"Cell"},{"key":"52285_CR43","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1053\/j.gastro.2018.10.030","volume":"156","author":"L Wang-Bishop","year":"2019","unstructured":"Wang-Bishop, L. et al. Inhibition of AURKA reduces proliferation and survival of gastrointestinal cancer cells with activated KRAS by preventing activation of RPS6KB1. Gastroenterology 156, 662\u2013675.e7 (2019).","journal-title":"Gastroenterology"},{"key":"52285_CR44","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature11935","volume":"494","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A. et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 494, 492\u2013496 (2013).","journal-title":"Nature"},{"key":"52285_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrg3123","volume":"13","author":"DJ Gordon","year":"2012","unstructured":"Gordon, D. J., Resio, B. & Pellman, D. Causes and consequences of aneuploidy in cancer. Nat Rev Genet 13, 189\u2013203 (2012).","journal-title":"Nat Rev Genet"},{"key":"52285_CR46","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.cell.2019.10.007","volume":"179","author":"DJ Clark","year":"2019","unstructured":"Clark, D. J. et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell 179, 964\u2013983.e31 (2019).","journal-title":"Cell"},{"key":"52285_CR47","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrc3916","volume":"15","author":"H Gaillard","year":"2015","unstructured":"Gaillard, H., Garcia-Muse, T. & Aguilera, A. Replication stress and cancer. Nat Rev Cancer 15, 276\u2013289 (2015).","journal-title":"Nat Rev Cancer"},{"key":"52285_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","volume":"22","author":"AABA da Costa","year":"2023","unstructured":"da Costa, A. A. B. A., Chowdhury, D., Shapiro, G. I., D\u2019Andrea, A. D. & Konstantinopoulos, P. A. Targeting replication stress in cancer therapy. Nat. Rev. Drug Discov. 22, 38\u201358 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"52285_CR49","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.ccell.2020.04.002","volume":"37","author":"P Msaouel","year":"2020","unstructured":"Msaouel, P. et al. Comprehensive molecular characterization identifies distinct genomic and immune hallmarks of renal medullary carcinoma. Cancer Cell 37, 720\u2013734.e13 (2020).","journal-title":"Cancer Cell"},{"key":"52285_CR50","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1053\/j.gastro.2020.09.043","volume":"160","author":"SB Dreyer","year":"2021","unstructured":"Dreyer, S. B. et al. Targeting DNA damage response and replication stress in pancreatic cancer. Gastroenterology 160, 362\u2013377.e13 (2021).","journal-title":"Gastroenterology"},{"key":"52285_CR51","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","volume":"82","author":"S Saxena","year":"2022","unstructured":"Saxena, S. & Zou, L. Hallmarks of DNA replication stress. Mol. Cell 82, 2298\u20132314 (2022).","journal-title":"Mol. Cell"},{"key":"52285_CR52","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-012414-040424","volume":"10","author":"M Macheret","year":"2015","unstructured":"Macheret, M. & Halazonetis, T. D. DNA replication stress as a hallmark of cancer. Annu. Rev. Pathol. 10, 425\u2013448 (2015).","journal-title":"Annu. Rev. Pathol."},{"key":"52285_CR53","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12929-021-00743-5","volume":"28","author":"CL Hsu","year":"2021","unstructured":"Hsu, C. L., Chong, S. Y., Lin, C. Y. & Kao, C. F. Histone dynamics during DNA replication stress. J. Biomed. Sci. 28, 48 (2021).","journal-title":"J. Biomed. Sci."},{"key":"52285_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nrg3345","volume":"14","author":"M Papamichos-Chronakis","year":"2013","unstructured":"Papamichos-Chronakis, M. & Peterson, C. L. Chromatin and the genome integrity network. Nat. Rev. Genet. 14, 62\u201375 (2013).","journal-title":"Nat. Rev. Genet."},{"key":"52285_CR55","doi-asserted-by":"crossref","unstructured":"Zhang, J., Dai, Q., Park, D. & Deng, X. Targeting DNA replication stress for cancer therapy. Genes (Basel) 7, 51 (2016).","DOI":"10.3390\/genes7080051"},{"key":"52285_CR56","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent, L. N. & Leone, G. The broken cycle: E2F dysfunction in cancer. Nat. Rev. Cancer 19, 326\u2013338 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"52285_CR57","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.celrep.2016.04.036","volume":"15","author":"C Bertoli","year":"2016","unstructured":"Bertoli, C., Herlihy, A. E., Pennycook, B. R., Kriston-Vizi, J. & de Bruin, R. A. M. Sustained E2F-dependent transcription is a key mechanism to prevent replication-stress-induced DNA damage. Cell Rep. 15, 1412\u20131422 (2016).","journal-title":"Cell Rep."},{"key":"52285_CR58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres, M. & Barbacid, M. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer 9, 153\u2013166 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"52285_CR59","doi-asserted-by":"publisher","first-page":"32017","DOI":"10.1038\/s41467-022-32017-5","volume":"13","author":"S Crowl","year":"2022","unstructured":"Crowl, S., Jordan, B. T., Ahmed, H., Ma, C. X. & Naegle, K. M. KSTAR: An algorithm to predict patientspecific kinase activities from phosphoproteomic data. Nat. Commun. 13, 32017\u20135 (2022).","journal-title":"Nat. Commun."},{"key":"52285_CR60","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41586-020-2481-8","volume":"583","author":"G Middleton","year":"2020","unstructured":"Middleton, G. et al. The national lung matrix trial of personalized therapy in lung cancer. Nature 583, 807\u2013812 (2020).","journal-title":"Nature"},{"key":"52285_CR61","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1063\/1.1336826","volume":"11","author":"BD Aguda","year":"2001","unstructured":"Aguda, B. D. Kick-starting the cell cycle: from growth-factor stimulation to initiation of DNA replication. Chaos 11, 269\u2013276 (2001).","journal-title":"Chaos"},{"key":"52285_CR62","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1074\/jbc.M604457200","volume":"282","author":"P Tenca","year":"2007","unstructured":"Tenca, P. et al. Cdc7 is an active kinase in human cancer cells undergoing replication stress. J. Biol. Chem. 282, 208\u2013215 (2007).","journal-title":"J. Biol. Chem."},{"key":"52285_CR63","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2443.2003.00647.x","volume":"8","author":"N Sato","year":"2003","unstructured":"Sato, N. et al. Cell cycle regulation of chromatin binding and nuclear localization of human Cdc7-ASK kinase complex. Genes Cells 8, 451\u2013463 (2003).","journal-title":"Genes Cells"},{"key":"52285_CR64","doi-asserted-by":"publisher","first-page":"29042","DOI":"10.1074\/jbc.M002713200","volume":"275","author":"H Masai","year":"2000","unstructured":"Masai, H. et al. Human Cdc7-related kinase complex -: phosphorylation of MCM by concerted actions of Cdks and Cdc7 and that of a critical threonine residue of Cdc7 by Cdks. J. Biol. Chem. 275, 29042\u201329052 (2000).","journal-title":"J. Biol. Chem."},{"key":"52285_CR65","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/jor.23819","volume":"36","author":"T Liu","year":"2018","unstructured":"Liu, T. et al. CDK4 expression in chordoma: a potential therapeutic target. J. Orthop. Res. 36, 1581\u20131589 (2018).","journal-title":"J. Orthop. Res."},{"key":"52285_CR66","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.molcel.2020.12.034","volume":"81","author":"AK Hopp","year":"2021","unstructured":"Hopp, A. K. et al. Mitochondrial NAD(+) controls nuclear ARTD1-Induced ADP-Ribosylation. Mol. Cell 81, 340\u2013354 e345 (2021).","journal-title":"Mol. Cell"},{"key":"52285_CR67","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.tcb.2007.07.010","volume":"17","author":"MJ Baker","year":"2007","unstructured":"Baker, M. J., Frazier, A. E., Gulbis, J. M. & Ryan, M. T. Mitochondrial protein-import machinery: correlating structure with function. Trends Cell Biol. 17, 456\u2013464 (2007).","journal-title":"Trends Cell Biol."},{"key":"52285_CR68","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath, S. et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 49, D1541\u2013D1547 (2021).","journal-title":"Nucleic Acids Res."},{"key":"52285_CR69","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41586-022-05641-w","volume":"614","author":"U Schulte","year":"2023","unstructured":"Schulte, U. et al. Mitochondrial complexome reveals quality-control pathways of protein import. Nature 614, 153 (2023).","journal-title":"Nature"},{"key":"52285_CR70","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1146\/annurev-biophys-121219-081604","volume":"49","author":"LH Ruan","year":"2020","unstructured":"Ruan, L. H. et al. Mitochondria-associated proteostasis. Annu. Rev. Biophys. 49, 41\u201367 (2020).","journal-title":"Annu. Rev. Biophys."},{"key":"52285_CR71","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cmet.2020.07.017","volume":"32","author":"H Antonicka","year":"2020","unstructured":"Antonicka, H. et al. A high-density human mitochondrial proximity interaction network. Cell Metab. 32, 479 (2020).","journal-title":"Cell Metab."},{"key":"52285_CR72","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrm.2017.110","volume":"19","author":"T Shpilka","year":"2018","unstructured":"Shpilka, T. & Haynes, C. M. The mitochondrial UPR: mechanisms, physiological functions and implications in ageing. Nat. Rev. Mol. Cell Biol. 19, 109\u2013120 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"52285_CR73","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.exphem.2022.03.008","volume":"110","author":"DE Shabashvili","year":"2022","unstructured":"Shabashvili, D. E., Feng, Y., Kaur, P., Venugopal, K. & Guryanova, O. A. Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations. Exp. Hematol. 110, 20\u201327 (2022).","journal-title":"Exp. Hematol."},{"key":"52285_CR74","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. S. Cancer metabolism: looking forward. Nat. Rev. Cancer 21, 669\u2013680 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"52285_CR75","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, 152 (2020).","journal-title":"Science"},{"key":"52285_CR76","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1182\/blood.2021012081","volume":"139","author":"AC Wilke","year":"2022","unstructured":"Wilke, A. C. et al. SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma. Blood 139, 538\u2013553 (2022).","journal-title":"Blood"},{"key":"52285_CR77","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/annonc\/mdx054","volume":"28","author":"S Stacchiotti","year":"2017","unstructured":"Stacchiotti, S. et al. Best practices for the management of local-regional recurrent chordoma: a position paper by the chordoma global consensus group. Ann. Oncol. 28, 1230\u20131242 (2017).","journal-title":"Ann. Oncol."},{"key":"52285_CR78","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","volume":"35","author":"YZ Jiang","year":"2019","unstructured":"Jiang, Y. Z. et al. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies. Cancer Cell 35, 428\u2013440.e5 (2019).","journal-title":"Cancer Cell"},{"key":"52285_CR79","doi-asserted-by":"crossref","unstructured":"Li, Y. et al. Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies. Nat. Commun. 13, 5723 (2022).","DOI":"10.1038\/s41467-022-33282-0"},{"key":"52285_CR80","doi-asserted-by":"crossref","unstructured":"Huang, R. X. & Zhou, P. K. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct. Target Ther. 5, 60 (2020).","DOI":"10.1038\/s41392-020-0150-x"},{"key":"52285_CR81","doi-asserted-by":"crossref","unstructured":"Huang, R. X. & Zhou, P. K. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct. Target Ther. 6, 254 (2021).","DOI":"10.1038\/s41392-021-00648-7"},{"key":"52285_CR82","doi-asserted-by":"publisher","first-page":"5685","DOI":"10.1158\/0008-5472.CAN-19-1323","volume":"79","author":"KD Castle","year":"2019","unstructured":"Castle, K. D. & Kirsch, D. G. Establishing the impact of vascular damage on tumor response to high-dose radiation therapy. Cancer Res. 79, 5685\u20135692 (2019).","journal-title":"Cancer Res."},{"key":"52285_CR83","doi-asserted-by":"publisher","first-page":"245ra93","DOI":"10.1126\/scitranslmed.3008973","volume":"6","author":"V Favaudon","year":"2014","unstructured":"Favaudon, V. et al. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci. Transl. Med. 6, 245ra93 (2014).","journal-title":"Sci. Transl. Med."},{"key":"52285_CR84","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","volume":"23","author":"TA Knijnenburg","year":"2018","unstructured":"Knijnenburg, T. A. et al. Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas. Cell Rep. 23, 239\u2013254 e236 (2018).","journal-title":"Cell Rep."},{"key":"52285_CR85","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1158\/1078-0432.CCR-17-1118","volume":"24","author":"EA Motea","year":"2018","unstructured":"Motea, E. A. et al. Kub5-Hera (RPRD1B) deficiency promotes \u201cBRCAness\u201d and vulnerability to PARP inhibition in BRCA-proficient breast cancers. Clin. Cancer Res. 24, 6459\u20136470 (2018).","journal-title":"Clin. Cancer Res."},{"key":"52285_CR86","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41388-020-01544-0","volume":"40","author":"M Li","year":"2021","unstructured":"Li, M., Ma, D. & Chang, Z. Current understanding of CREPT and p15RS, carboxy-terminal domain (CTD)-interacting proteins, in human cancers. Oncogene 40, 705\u2013716 (2021).","journal-title":"Oncogene"},{"key":"52285_CR87","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/nar\/gkv1492","volume":"44","author":"PL Patidar","year":"2016","unstructured":"Patidar, P. L. et al. The Kub5-Hera\/RPRD1B interactome: a novel role in preserving genetic stability by regulating DNA mismatch repair. Nucleic Acids Res .44, 1718\u20131731 (2016).","journal-title":"Nucleic Acids Res"},{"key":"52285_CR88","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1101\/gad.1933010","volume":"24","author":"K Labib","year":"2010","unstructured":"Labib, K. How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in eukaryotic cells? Genes Dev. 24, 1208\u20131219 (2010).","journal-title":"Genes Dev."},{"key":"52285_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."},{"key":"52285_CR90","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature24050","volume":"550","author":"Z Dou","year":"2017","unstructured":"Dou, Z. et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550, 402\u2013406 (2017).","journal-title":"Nature"},{"key":"52285_CR91","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.devcel.2017.05.022","volume":"41","author":"S Santaguida","year":"2017","unstructured":"Santaguida, S. et al. Chromosome mis-segregation generates cell-cycle-arrested cells with complex karyotypes that are eliminated by the immune system. Dev. Cell 41, 638\u2013651 e635 (2017).","journal-title":"Dev. Cell"},{"key":"52285_CR92","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ccell.2016.12.004","volume":"31","author":"JM Sheltzer","year":"2017","unstructured":"Sheltzer, J. M. et al. Single-chromosome gains commonly function as tumor suppressors. Cancer Cell 31, 240\u2013255 (2017).","journal-title":"Cancer Cell"},{"key":"52285_CR93","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cell.2018.08.027","volume":"174","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum, S. F. & Cantley, L. C. The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell 174, 1347\u20131360 (2018).","journal-title":"Cell"},{"key":"52285_CR94","doi-asserted-by":"crossref","unstructured":"Liu, T., Zhang, L., Joo, D. & Sun, S. C. NF-kappaB signaling in inflammation. Signal Transduct. Target Ther. 2, 17023 (2017).","DOI":"10.1038\/sigtrans.2017.23"},{"key":"52285_CR95","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi, K. & Karin, M. NF-kappaB, inflammation, immunity and cancer: coming of age. Nat. Rev. Immunol. 18, 309\u2013324 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"52285_CR96","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/j.seminoncol.2015.02.002","volume":"42","author":"E Cha","year":"2015","unstructured":"Cha, E., Wallin, J. & Kowanetz, M. PD-L1 inhibition with MPDL3280A for solid tumors. Semin. Oncol. 42, 484\u2013487 (2015).","journal-title":"Semin. Oncol."},{"key":"52285_CR97","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.3390\/cancers13102408","volume":"13","author":"JI Traylor","year":"2021","unstructured":"Traylor, J. I., Pernik, M. N., Plitt, A. R., Lim, M. & Garzon-Muvdi, T. Immunotherapy for chordoma and chondrosarcoma: current evidence. Cancers 13, 2408 (2021).","journal-title":"Cancers"},{"key":"52285_CR98","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/cancers15010264","volume":"15","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Immunotherapy as a promising option for the treatment of advanced chordoma: a systemic review. Cancers 15, 264 (2023).","journal-title":"Cancers"},{"key":"52285_CR99","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1158\/1078-0432.CCR-05-1938","volume":"12","author":"H Ishimura","year":"2006","unstructured":"Ishimura, H. et al. N-acetylglucosaminyltransferase V and \u03b21-6 branching-linked oligosaccharides are associated with good prognosis of patients with bladder cancer. Clin. Cancer Res. 12, 2506\u20132511 (2006).","journal-title":"Clin. Cancer Res."},{"key":"52285_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02391-6","volume":"9","author":"M Schubert","year":"2018","unstructured":"Schubert, M. et al. Perturbation-response genes reveal signaling footprints in cancer gene expression. Nat. Commun. 9, 20 (2018).","journal-title":"Nat. Commun."},{"key":"52285_CR101","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00428-005-1264-9","volume":"446","author":"X Dolcet","year":"2005","unstructured":"Dolcet, X., Llobet, D., Pallares, J. & Matias-Guiu, X. NF-kB in development and progression of human cancer. Virchows Arch. 446, 475\u2013482 (2005).","journal-title":"Virchows Arch."},{"key":"52285_CR102","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrm2239","volume":"8","author":"MC Maiuri","year":"2007","unstructured":"Maiuri, M. C., Zalckvar, E., Kimchi, A. & Kroemer, G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 8, 741\u2013752 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"52285_CR103","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/biof.1112","volume":"39","author":"E Oikonomou","year":"2013","unstructured":"Oikonomou, E. & Pintzas, A. The TRAIL of oncogenes to apoptosis. Biofactors 39, 343\u2013354 (2013).","journal-title":"Biofactors"},{"key":"52285_CR104","doi-asserted-by":"publisher","unstructured":"Taciak, B., Pruszynska, I., Kiraga, L., Bialasek, M. & Krol, M. Wnt signaling pathway in development and cancer. J. Physiol. Pharmacol. https:\/\/doi.org\/10.26402\/jpp.2018.2.07 (2018).","DOI":"10.26402\/jpp.2018.2.07"},{"key":"52285_CR105","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1038\/sj.emboj.7600302","volume":"23","author":"N Clarke","year":"2004","unstructured":"Clarke, N., Jimenez-Lara, A. M., Voltz, E. & Gronemeyer, H. Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. EMBO J. 23, 3051\u20133060 (2004).","journal-title":"EMBO J."},{"key":"52285_CR106","doi-asserted-by":"publisher","first-page":"872","DOI":"10.4161\/cbt.6.6.4088","volume":"6","author":"A Papageorgiou","year":"2007","unstructured":"Papageorgiou, A., Dinney, C. P. & McConkey, D. J. Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells. Cancer Biol. Ther. 6, 872\u2013879 (2007).","journal-title":"Cancer Biol. Ther."},{"key":"52285_CR107","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10738","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding, L. et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506\u2013510 (2012).","journal-title":"Nature"},{"key":"52285_CR108","unstructured":"Morrissy, A. S. et al. Divergent clonal selection dominates medulloblastoma at recurrence. Nature 529, 351\u2013357, (2016)."},{"key":"52285_CR109","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10577-010-9179-y","volume":"19","author":"SL Thompson","year":"2011","unstructured":"Thompson, S. L. & Compton, D. A. Chromosomes and cancer cells. Chromosome Res. 19, 433\u2013444 (2011).","journal-title":"Chromosome Res."},{"key":"52285_CR110","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ajhg.2009.01.024","volume":"84","author":"MF Arlt","year":"2009","unstructured":"Arlt, M. F. et al. Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants. Am. J. Hum. Genet. 84, 339\u2013350 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"52285_CR111","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.omtn.2021.07.002","volume":"26","author":"GD Liu","year":"2021","unstructured":"Liu, G. D. et al. E2F3 promotes liver cancer progression under the regulation of circ-PRKAR1B. Mol. Ther.Nucl Acids 26, 104\u2013113 (2021).","journal-title":"Mol. Ther.Nucl Acids"},{"key":"52285_CR112","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1177\/15353702211035693","volume":"246","author":"S Jusino","year":"2021","unstructured":"Jusino, S. et al. E2F3 drives the epithelial-to-mesenchymal transition, cell invasion, and metastasis in breast cancer. Exp. Biol. Med. 246, 2057\u20132071 (2021).","journal-title":"Exp. Biol. Med."},{"key":"52285_CR113","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3892\/ol.2021.12672","volume":"21","author":"L Wu","year":"2021","unstructured":"Wu, L. et al. Expression and prognostic value of E2F3 transcription factor in non-small cell lung cancer. Oncol. Lett. 21, 411 (2021).","journal-title":"Oncol. Lett."},{"key":"52285_CR114","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.18632\/oncotarget.2928","volume":"6","author":"JM Lee","year":"2015","unstructured":"Lee, J. M., Heo, M. J., Lee, C. G., Yang, Y. M. & Kim, S. G. Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer, directly inhibits E2F3, sensitizing mesenchymal tumor cells to anti-cancer agents. Oncotarget 6, 3918\u20133931 (2015).","journal-title":"Oncotarget"},{"key":"52285_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14605-5","volume":"11","author":"A Bhattacharya","year":"2020","unstructured":"Bhattacharya, A. et al. Transcriptional effects of copy number alterations in a large set of human cancers. Nat. Commun. 11, 715 (2020).","journal-title":"Nat. Commun."},{"key":"52285_CR116","doi-asserted-by":"publisher","first-page":"eaaf8399","DOI":"10.1126\/science.aaf8399","volume":"355","author":"T Davoli","year":"2017","unstructured":"Davoli, T., Uno, H., Wooten, E. C. & Elledge, S. J. Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science 355, eaaf8399 (2017).","journal-title":"Science"},{"key":"52285_CR117","doi-asserted-by":"crossref","unstructured":"Rajkumar, S. V. & Kumar, S. Multiple myeloma current treatment algorithms. Blood Cancer J. 10, 94 (2020).","DOI":"10.1038\/s41408-020-00359-2"},{"key":"52285_CR118","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cancergen.2014.06.025","volume":"207","author":"VT Fabris","year":"2014","unstructured":"Fabris, V. T. From chromosomal abnormalities to the identification of target genes in mouse models of breast cancer. Cancer Genet. 207, 233\u2013246 (2014).","journal-title":"Cancer Genet."},{"key":"52285_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25709-x","volume":"12","author":"J DeSisto","year":"2021","unstructured":"DeSisto, J. et al. Comprehensive molecular characterization of pediatric radiation-induced high-grade glioma. Nat. Commun. 12, 5531 (2021).","journal-title":"Nat. Commun."},{"key":"52285_CR120","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1042\/BCJ20190654","volume":"477","author":"K Mohanraj","year":"2020","unstructured":"Mohanraj, K., Nowicka, U. & Chacinska, A. Mitochondrial control of cellular protein homeostasis. Biochem. J. 477, 3033\u20133054 (2020).","journal-title":"Biochem. J."},{"key":"52285_CR121","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","volume":"61","author":"WX Zong","year":"2016","unstructured":"Zong, W. X., Rabinowitz, J. D. & White, E. Mitochondria and cancer. Mol. Cell 61, 667\u2013676 (2016).","journal-title":"Mol. Cell"},{"key":"52285_CR122","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13046-018-0758-7","volume":"37","author":"L Tang","year":"2018","unstructured":"Tang, L. et al. Role of metabolism in cancer cell radioresistance and radiosensitization methods. J. Exp. Clin. Cancer Res. 37, 87 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"52285_CR123","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/09553002.2014.937511","volume":"91","author":"I Dokic","year":"2015","unstructured":"Dokic, I. et al. High resistance to X-rays and therapeutic carbon ions in glioblastoma cells bearing dysfunctional ATM associates with intrinsic chromosomal instability. Int. J. Radiat Biol. 91, 157\u2013165 (2015).","journal-title":"Int. J. Radiat Biol."},{"key":"52285_CR124","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1158\/1078-0432.CCR-08-1307","volume":"15","author":"TJ Kinsella","year":"2009","unstructured":"Kinsella, T. J. Coordination of DNA mismatch repair and base excision repair processing of chemotherapy and radiation damage for targeting resistant cancers. Clin. Cancer Res. 15, 1853\u20131859 (2009).","journal-title":"Clin. Cancer Res."},{"key":"52285_CR125","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.semradonc.2010.05.005","volume":"20","author":"C Vens","year":"2010","unstructured":"Vens, C. & Begg, A. C. Targeting base excision repair as a sensitization strategy in radiotherapy. Semin. Radiat. Oncol. 20, 241\u2013249 (2010).","journal-title":"Semin. Radiat. Oncol."},{"key":"52285_CR126","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ctrv.2009.06.005","volume":"35","author":"Y Zhu","year":"2009","unstructured":"Zhu, Y., Hu, J., Hu, Y. & Liu, W. Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance. Cancer Treat. Rev. 35, 590\u2013596 (2009).","journal-title":"Cancer Treat. Rev."},{"key":"52285_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25894-9","volume":"12","author":"G Han","year":"2021","unstructured":"Han, G. et al. 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. Nat. Commun. 12, 5606 (2021).","journal-title":"Nat. Commun."},{"key":"52285_CR128","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/pros.10173","volume":"54","author":"H Matsuyama","year":"2003","unstructured":"Matsuyama, H. et al. Clinical significance of chromosome 8p, 10q and 16q deletions in prostate cancer. Prostate 54, 103\u2013111 (2003).","journal-title":"Prostate"},{"key":"52285_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1440-1789.2004.00600.x","volume":"25","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki, H. Genetic pathways to glioblastomas. Neuropathology 25, 1\u20137 (2005).","journal-title":"Neuropathology"},{"key":"52285_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29577-x","volume":"13","author":"YY Qu","year":"2022","unstructured":"Qu, Y. Y. et al. A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population. Nat. Commun. 13, 2052 (2022).","journal-title":"Nat. Commun."},{"key":"52285_CR131","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1053\/j.gastro.2023.11.284","volume":"166","author":"M Sun","year":"2024","unstructured":"Sun, M. et al. Proteomic characterization identifies clinically relevant subgroups of gastrointestinal stromal tumors. Gastroenterology 166, 450\u2013465.e433 (2024).","journal-title":"Gastroenterology"},{"key":"52285_CR132","doi-asserted-by":"publisher","first-page":"6039","DOI":"10.1158\/1078-0432.CCR-19-2773","volume":"26","author":"C Marusak","year":"2020","unstructured":"Marusak, C. et al. Targeting extracellular matrix remodeling restores BRAF inhibitor sensitivity in BRAFi-resistant melanoma. Clin. Cancer Res. 26, 6039\u20136050 (2020).","journal-title":"Clin. Cancer Res."},{"key":"52285_CR133","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","volume":"15","author":"YF Jiang","year":"2022","unstructured":"Jiang, Y. F. et al. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J. Hematol. Oncol. 15, 34 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"52285_CR134","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/path.2679","volume":"220","author":"J Sommer","year":"2010","unstructured":"Sommer, J. et al. Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor\/insulin receptor: potential therapeutic targets in chordoma. J. Pathol. 220, 608\u2013617 (2010).","journal-title":"J. Pathol."},{"key":"52285_CR135","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","volume":"547","author":"PA Northcott","year":"2017","unstructured":"Northcott, P. A. et al. The whole-genome landscape of medulloblastoma subtypes. Nature 547, 311 (2017).","journal-title":"Nature"},{"key":"52285_CR136","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3857\/roj.2022.00444","volume":"41","author":"WK Cho","year":"2023","unstructured":"Cho, W. K. et al. Liquid biopsy using cfDNA to predict radiation therapy response in solid tumors. Radiat. Oncol. J. 41, 32\u201339 (2023).","journal-title":"Radiat. Oncol. J."},{"key":"52285_CR137","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41421-022-00459-2","volume":"8","author":"QL Zhang","year":"2022","unstructured":"Zhang, Q. L. et al. Single-cell transcriptome reveals cellular hierarchies and guides p-EMT-targeted trial in skull base chordoma. Cell Discov. 8, 94 (2022).","journal-title":"Cell Discov."},{"key":"52285_CR138","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/neuonc\/noab235","volume":"24","author":"JA Zuccato","year":"2022","unstructured":"Zuccato, J. A. et al. DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma. Neuro Oncology. 24, 442\u2013454 (2022).","journal-title":"Neuro Oncology."},{"key":"52285_CR139","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03198-w","volume":"24","author":"X Li","year":"2024","unstructured":"Li, X. et al. Identification of TNFRSF21 as an inhibitory factor of osteosarcoma based on a necroptosis-related prognostic gene signature and molecular experiments. Cancer Cell Int. 24, 14 (2024).","journal-title":"Cancer Cell Int."},{"key":"52285_CR140","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1111\/cas.15131","volume":"112","author":"T Lei","year":"2021","unstructured":"Lei, T., Qian, H., Lei, P. F. & Hu, Y. H. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma. Cancer Sci. 112, 4785\u20134798 (2021).","journal-title":"Cancer Sci."},{"key":"52285_CR141","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"52285_CR142","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cels.2017.09.003","volume":"5","author":"BH Hristov","year":"2017","unstructured":"Hristov, B. H. & Singh, M. Network-based coverage of mutational profiles reveals cancer genes. Cell Syst. 5, 221\u2013229 e224 (2017).","journal-title":"Cell Syst."},{"key":"52285_CR143","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cels.2018.03.002","volume":"6","author":"K Ellrott","year":"2018","unstructured":"Ellrott, K. et al. Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines. Cell Syst. 6, 271\u2013281.e7 (2018).","journal-title":"Cell Syst."},{"key":"52285_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, r41 (2011).","journal-title":"Genome Biol."},{"key":"52285_CR145","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359\u2013U360 (2009).","journal-title":"Nat. Methods"},{"key":"52285_CR146","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nbt.3825","volume":"35","author":"J Feng","year":"2017","unstructured":"Feng, J. et al. Firmiana: towards a one-stop proteomic cloud platform for data processing and analysis. Nat. Biotechnol. 35, 409\u2013412 (2017).","journal-title":"Nat. Biotechnol."},{"key":"52285_CR147","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.cell.2020.10.036","volume":"183","author":"K Krug","year":"2020","unstructured":"Krug, K. et al. Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy. Cell 183, 1436 (2020).","journal-title":"Cell"},{"key":"52285_CR148","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1016\/j.cell.2021.07.016","volume":"184","author":"S Satpathy","year":"2021","unstructured":"Satpathy, S. et al. A proteogenomic portrait of lung squamous cell carcinoma. Cell 184, 4348 (2021).","journal-title":"Cell"},{"key":"52285_CR149","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","volume":"182","author":"JY Xu","year":"2020","unstructured":"Xu, J. Y. et al. Integrative proteomic characterization of human lung adenocarcinoma. Cell 182, 245 (2020).","journal-title":"Cell"},{"key":"52285_CR150","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","volume":"567","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y. et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature 567, 257 (2019).","journal-title":"Nature"},{"key":"52285_CR151","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1101\/gr.240663.118","volume":"29","author":"L Garcia-Alonso","year":"2019","unstructured":"Garcia-Alonso, L., Holland, C. H., Ibrahim, M. M., Turei, D. & Saez-Rodriguez, J. Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res. 29, 1363\u20131375 (2019).","journal-title":"Genome Res."},{"key":"52285_CR152","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1093\/nar\/gkq149","volume":"38","author":"A Essaghir","year":"2010","unstructured":"Essaghir, A. et al. Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data. Nucleic Acids Res. 38, e120 (2010).","journal-title":"Nucleic Acids Res."},{"key":"52285_CR153","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic-driven cancers require TBK1. Nature 462, 108\u2013U122 (2009).","journal-title":"Nature"},{"key":"52285_CR154","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-Seq data. Bmc Bioinform. 14, 7 (2013).","journal-title":"Bmc Bioinform."},{"key":"52285_CR155","doi-asserted-by":"publisher","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","volume":"50","author":"T Chen","year":"2022","unstructured":"Chen, T. et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 50, D1522\u2013D1527 (2022).","journal-title":"Nucleic Acids Res."},{"key":"52285_CR156","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. iProX: an integrated proteome resource. Nucleic Acids Res. 47, D1211\u2013D1217 (2019).","journal-title":"Nucleic Acids Res."},{"key":"52285_CR157","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/pmic.200300772","volume":"4","author":"PV Hornbeck","year":"2004","unstructured":"Hornbeck, P. V., Chabra, I., Kornhauser, J. M., Skrzypek, E. & Zhang, B. Phosphosite: A bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 4, 1551\u20131561 (2004).","journal-title":"Proteomics"},{"key":"52285_CR158","doi-asserted-by":"publisher","first-page":"D240","DOI":"10.1093\/nar\/gkm772","volume":"36","author":"F Diella","year":"2008","unstructured":"Diella, F., Gould, C. M., Chica, C., Via, A. & Gibson, T. J. Phospho.ELM: a database of phosphorylation sites - update 2008. Nucleic Acids Res. 36, D240\u2013D244 (2008).","journal-title":"Nucleic Acids Res."},{"key":"52285_CR159","doi-asserted-by":"publisher","first-page":"I14","DOI":"10.1093\/bioinformatics\/btn297","volume":"24","author":"CY Yang","year":"2008","unstructured":"Yang, C. Y. et al. PhosphoPOINT: a comprehensive human kinase interactome and phospho-protein database. Bioinformatics 24, I14\u2013I20 (2008).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52285-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52285-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52285-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T12:03:33Z","timestamp":1727697813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52285-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52285"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52285-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"9 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8338"}}